Contemplations on MDMX (MDM4) driving triple negative breast cancer circulating tumor cells and metastasis

MDMX (MDM4) is emerging as an important breast cancer (BC) biomarker, and oncoprotein, that can be targeted in combination with its well-known family member MDM2. While MDM2 has previously been implicated in driving BC metastasis, information about the role of MDMX in driving circulating tumor cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Chong, Xiao, Gu, Bargonetti, Jill
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707941/
https://www.ncbi.nlm.nih.gov/pubmed/31489110
http://dx.doi.org/10.18632/oncotarget.27134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707941/
https://www.ncbi.nlm.nih.gov/pubmed/31489110
http://dx.doi.org/10.18632/oncotarget.27134

Ejemplares similares